Aditya Birla Sun Life Pharma & Healthcare Fund

Aditya Birla Sun Life Mutual FundThematicPortfolio as of 30 September 2026

Aditya Birla Sun Life Pharma & Healthcare Fund holds 41 instruments (97.94% equity), led by Torrent Pharmaceuticals Limited (9.28%), Sun Pharmaceutical Industries Limited (8.61%) and Apollo Hospitals Enterprise Limited (6.44%), as of its 30 September 2026 SEBI-mandated monthly disclosure.

Holdings
41
Equity Allocation
97.94%
AMC
Aditya Birla Sun Life Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of Aditya Birla Sun Life Pharma & Healthcare Fund, managed by Aditya Birla Sun Life Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 41 instruments with an equity allocation of 97.94%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund's top 10 holdings account for 54.46% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 96.52% of net assets, spread across 3 sectors in total. Since its 31 August 2026 disclosure, the fund added 0 new positions and exited 0 positions, with Dr. Lal Path Labs Ltd. seeing the largest move (+1.41pp to 3.51%).

Sector Breakdown

Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.

Healthcare
96.52%
Other
2.07%
Financial Services
0.73%
Materials
0.69%

Top 10 Equity Holdings

What Changed: August 2026 → September 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

10 increased8 reduced

Biggest Weight Increases

StockWeightChange
Dr. Lal Path Labs Ltd.2.1% → 3.51%▲ +1.41
Cipla Limited5.16% → 6.38%▲ +1.22
Sai Life Sciences Limited4.2% → 4.49%▲ +0.29
Biocon Limited1.19% → 1.45%▲ +0.26
Abbott India Limited3.03% → 3.26%▲ +0.23
Emcure Pharmaceuticals Limited2.99% → 3.21%▲ +0.22
Mankind Pharma Limited3.41% → 3.62%▲ +0.21
Shilpa Medicare Limited1.27% → 1.43%▲ +0.16
Ajanta Pharma Limited4.22% → 4.35%▲ +0.13
Jubilant Pharmova Limited0.5% → 0.6%▲ +0.1

Biggest Weight Reductions

StockWeightChange
Sun Pharmaceutical Industries Limited9.19% → 8.61%▼ -0.58
Apollo Hospitals Enterprise Limited6.85% → 6.44%▼ -0.41
Fortis Healthcare Limited2.79% → 2.42%▼ -0.37
Torrent Pharmaceuticals Limited9.57% → 9.28%▼ -0.29
JUPITER LIFE LINE HOSPITALS1.76% → 1.55%▼ -0.21
Thyrocare Technologies Limited1.94% → 1.76%▼ -0.18
Pfizer Limited1.19% → 1.01%▼ -0.18
Lupin Limited3.1% → 2.94%▼ -0.16

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).

Apr: 4.76%, May: 4.75%, Jun: 4.68%, Jul: 9.94%, Aug: 9.57%, Sept: 9.28%
9.28%
Apr: 13.17%, May: 12.42%, Jun: 12.09%, Jul: 9.75%, Aug: 9.19%, Sept: 8.61%
8.61%
Apr: 7.2%, May: 7.31%, Jun: 7.3%, Jul: 7.08%, Aug: 6.85%, Sept: 6.44%
6.44%
Apr: 3.3%, May: 2.98%, Jun: 2.93%, Jul: 4.56%, Aug: 5.16%, Sept: 6.38%
6.38%
Apr: 4.49%, May: 4.37%, Jun: 4.55%, Jul: 4.29%, Aug: 4.54%, Sept: 4.52%
4.52%

Full Portfolio (41 holdings)

#HoldingSector% to NAV
1Torrent Pharmaceuticals LimitedHealthcare9.28%
2Sun Pharmaceutical Industries LimitedHealthcare8.61%
3Apollo Hospitals Enterprise LimitedHealthcare6.44%
4Cipla LimitedHealthcare6.38%
5Aurobindo Pharma LimitedHealthcare4.52%
6Sai Life Sciences LimitedHealthcare4.49%
7Ajanta Pharma LimitedHealthcare4.35%
8Mankind Pharma LimitedHealthcare3.62%
9Dr. Lal Path Labs Ltd.Healthcare3.51%
10Abbott India LimitedHealthcare3.26%
11Emcure Pharmaceuticals LimitedHealthcare3.21%
12Lupin LimitedHealthcare2.94%
13TREPStreps—2.92%
14IPCA Laboratories LimitedHealthcare2.71%
15Gland Pharma LimitedHealthcare2.7%
16Fortis Healthcare LimitedHealthcare2.42%
17CORONA Remedies LimitedHealthcare2.27%
18Divi's Laboratories LimitedHealthcare2.24%
19Procter & Gamble Health LimitedHealthcare1.82%
20Thyrocare Technologies LimitedHealthcare1.76%
21Alkem Laboratories LimitedHealthcare1.68%
22JUPITER LIFE LINE HOSPITALSHealthcare1.55%
23Metropolis Healthcare LimitedHealthcare1.48%
24Biocon LimitedHealthcare1.45%
25Shilpa Medicare LimitedHealthcare1.43%
26Piramal Pharma LimitedHealthcare1.22%
27Dr. Reddy's Laboratories LimitedHealthcare1.13%
28Anthem Biosciences LimitedHealthcare1.13%
29Sanofi Consumer Healthcare India LimitedHealthcare1.11%
30Suraksha Diagnostic LimitedHealthcare1.1%
31MANIPAL HEALTH ENTERPRISES LHealthcare1.07%
32Vijaya Diagnostic Centre LimitedHealthcare1.04%
33Pfizer LimitedHealthcare1.01%
34Natco Pharma LimitedHealthcare0.92%
35GlaxoSmithKline Pharmaceuticals LimitedHealthcare0.83%
36Medi Assist Healthcare Services LimitedFinancial Services0.73%
37Vinati Organics LimitedMaterials0.69%
38Syngene International LimitedHealthcare0.64%
39Max Healthcare Institute LimitedHealthcare0.6%
40Jubilant Pharmova LimitedHealthcare0.6%
41Net Receivable / Payableother—-0.85%

Frequently Asked Questions

Yes. As of its 30 September 2026 disclosure, Torrent Pharmaceuticals Limited is 9.28% of Aditya Birla Sun Life Pharma & Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 30 September 2026 disclosure, Sun Pharmaceutical Industries Limited is 8.61% of Aditya Birla Sun Life Pharma & Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 30 September 2026 disclosure, Apollo Hospitals Enterprise Limited is 6.44% of Aditya Birla Sun Life Pharma & Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 30 September 2026 disclosure, Cipla Limited is 6.38% of Aditya Birla Sun Life Pharma & Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 30 September 2026 disclosure, Aurobindo Pharma Limited is 4.52% of Aditya Birla Sun Life Pharma & Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: Aditya Birla Sun Life Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.